Yolanda Bryce

Ian del Conde M.D., FACC, FSVM, is a cardiologist and vascular medicine specialist at the Miami Cardiac & Vascular Institute.

He is the Director of Vascular Medicine and the Associate Director of Cardiology within the Miami Cardiac and Vascular Institute. Dr. Del Conde has authored numerous articles and book chapters that have been published in peer-reviewed periodicals, and has been an invited speaker to numerous national and international medical meetings.

His clinical research focuses on developing new diagnostic tools and therapies to advance the care of patients with cardiovascular disease. Dr. del Conde completed internal medicine residency training at Harvard’s Brigham and Women’s Hospital, and thn completed fellowship training in cardiology and vascular medicine at Mount Sinai School of Medicine, in New York City.

Brian Schiro, MD, RPVI, FSIR is a vascular and interventional radiologist at the Miami Cardiac & Vascular Institute in Miami, FL and is the medical director of the noninvasive vascular lab at Baptist Hospital of Miami. Dr. Schiro completed his fellowship training with Miami Vascular in vascular and interventional radiology in 2010 following his diagnostic radiology residency training at the University of Pittsburgh Medical Center. He received his medical degree from the Louisiana State University Health Sciences Center in 2004. Dr. Schiro now serves as the program director for the independent interventional radiology residency with Miami Vascular and is also the medical director for the medical sonography program at Nova Southeastern University. Dr. Schiro serves on the IAC Vascular Testing Board of Directors as a representative of the Society of Interventional Radiology (SIR). He has authored numerous articles in peer reviewed journals and his research interests include noninvasive imaging and diagnosis as well as peripheral vascular interventions.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

A graduate from Faculty of Medicine, Cairo University, Cairo, Egypt. Certified as a registered Physician in Vascular Interpretation RPVI and registered Vascular Technologist RVT by the ARDMS.
Currently responsible for Baptist Health South Florida system-wide echocardiography and noninvasive vascular testing clinical education, and accreditation by IAC. Maintaining standard performance, managing and updating competencies and QI programs for the system's medical and technical staff.

Dr. John S. Pellerito is Vice Chairman of the Department of Radiology, the Program Director for the Radiology Residency Program and Director of the Peripheral Vascular Laboratory at Northwell Health and Director of the Body Imaging Fellowship at North Shore University Hospital. He is Professor of Radiology and Science Education at the Zucker School of Medicine at Hofstra/Northwell and is co-director of the SONICS ultrasound program for medical students at the University. Dr. Pellerito graduated from New York University before receiving his M.D. from Albany Medical College. He served as faculty at Yale-New Haven Hospital before his current positions at Northwell Health. He is the co-editor of Introduction to Vascular Ultrasonography, in its 7th edition. He is author of multiple original articles and book chapters, and his current research interests include developing new imaging strategies for OB/GYN and cardiovascular diseases including 3D imaging and ultrasound contrast agents. Dr. Pellerito is in great demand as a speaker both nationally and internationally and currently holds multiple editorial appointments including Radiology, RadioGraphics and Journal of Ultrasound in Medicine. He was a board examiner for the American Board of Radiology. He serves on the Executive Committee of the American Institute of Ultrasound in Medicine (AIUM) and is currently on the Board of Directors for the Intersocietal Accreditation Commission for vascular testing (IAC). He currently serves on multiple committees, including the American College of Radiology, American Institute of Ultrasound in Medicine, Society of Ultrasound in Medical Education and the Society of Radiologists in Ultrasound.

Dr. Watch received her medical degree from the Sackler School of Medicine at Tel Aviv University in 2002. She completed her general surgery residency at the University of New Mexico and her vascular surgery fellowship at the Medical College of Wisconsin. She is board certified in General Surgery and Vascular Surgery. She is a Diplomate of the American College of Surgeons.

Dr. Watch's training involved a multidisciplinary approach to vascular disease, focusing both on open and endovascular therapies. She maintains a strong interest in carotid disease, endovascular aneurysm repair, endovascular and open treatment of critical limb ischemia, varicose vein treatment, TCAR procedures and dialysis access. She joined Miami Vascular Specialists in 2011.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016. She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she pioneers minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery and works in a multidisciplinary team to expand treatment options for patients with metastatic breast cancer through interventional oncology. She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s PAD program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her PAD screening trial examines the prevalence and disparities of PAD in at-risk cancer patients.

Dr. Raghu Kolluri, MD, serves as the System Chief of Vascular Medicine at OhioHealth, where he oversees the vascular division of the cardiovascular service line, driving quality, innovation, and system-wide clinical excellence. He is an Adjunct Clinical Professor of Medicine at Ohio University Heritage College of Osteopathic Medicine, where he remains deeply engaged in teaching and mentorship. As President of Syntropic Core Lab, Dr. Kolluri is a clinical trialist who advises on multiple ongoing vascular clinical trials and contributes to advancing evidence-based practice in vascular medicine. A past president of both the Society for Vascular Medicine and The VIVA Foundation, he has been recognized with the prestigious Master of the Society for Vascular Medicine (MSVM) designation. Dr. Kolluri also serves on the Board of Trustees of the Intersocietal Accreditation Council for Vascular Testing. He has authored numerous peer-reviewed publications, including in The New England Journal of Medicine and Circulation, as well as book chapters, scientific abstracts, and clinical guidelines.

Dr. Peter Schneider is Professor of Surgery at University of California, San Francisco and has a strong interest in education and training in vascular and endovascular techniques, clinical research in peripheral arterial disease, and device development for the treatment of vascular disease. He previously practiced at Kaiser Foundation Hospital in Honolulu where he was Chief of Vascular Therapy. He attended Johns Hopkins School of Medicine and then University of California San Francisco for vascular surgery. He has been invited to many visiting professorships and served as faculty or course director for dozens of specialty courses and international conferences. He authored Endovascular Skills currently in its 4th edition and is used internationally by vascular residents and fellows. He has served as President of the Western Vascular Society and VIVA.